Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

79 questions · 91 findings · 13 reviews

No studies found 19 · 20.9%GRADE not reported 2 · 2.2%Very low 26 · 28.6%Low 30 · 33%Moderate 14 · 15.4%High 0 · 0%

Clomiphene citrate or letrozole with or without gonadotropins (with or without midcycle antagonist) vs gonadotropins (with GnRH agonists or midcycle antagonist)

Clinical pregnancy rate · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)

Clomiphene citrate or letrozole with or without gonadotropins (with… showed no clear difference in clinical pregnancy rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).

1 finding from 1 review

Clomiphene citrate or letrozole with or without gonadotropins (with or without midcycle antagonist) vs gonadotropins (with GnRH agonists or midcycle antagonist)

Cancellation rate per woman · Women undergoing controlled ovarian stimulation in IVF and ICSI cycles (poor responders)

Clomiphene citrate or letrozole with or without gonadotropins (with… may leads to higher cancellation rate per woman compared with gonadotropins (with GnRH agonist or midcycle antagonist) (low certainty).

1 finding from 1 review

Intervention not reported

Seizure freedom (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy

The intervention showed no clear difference in seizure freedom (1‐ to 3‐month blinded evaluation periods) (moderate certainty).

1 finding from 1 review

Intervention not reported

Responder rate (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy

The intervention showed no clear difference in responder rate (1‐ to 3‐month blinded evaluation periods) (low certainty).

1 finding from 1 review

Intervention not reported

Seizure frequency (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review

Intervention not reported

Adverse events · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review

Intervention not reported

Neuropsychological outcome (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review

Intervention not reported

Quality of life (QOLIE‐89) (1‐ to 3‐month periods) · patients with refractory medial temporal lobe epilepsy
1 finding from 1 review